Infection reporting in patients undergoing irreversible electroporation of locally advanced pancreatic cancer

Author:

Filson Anthony1,Martin Robert C. G.1ORCID

Affiliation:

1. Division of Surgical Oncology, Department of Surgery University of Louisville Louisville Kentucky USA

Abstract

AbstractBackgroundIntraoperative bile cultures (IOBCs) taken during pancreatic surgery are commonly performed and there has been limited evidence that a positive IOBC could aid in perioperative adverse event (AE) management. Therefore, this study aims to describe infection management in patients undergoing irreversible electroporation (IRE).MethodsAn Institutional Review Board (IRB)‐approved prospective database was utilized from 8/2016 to 6/2022, with 127 pancreatic adenocarcinoma patients included.ResultsA total of 28 patients that underwent IRE also had a simultaneous positive IOBC and the remaining 99 patients that underwent IRE had negative IOBC. A total of 11(39%) of the patients with a positive IOBC had AE's, and 38 (38%) of the patients with negative IOBC had AE's. Both groups had similar rates of AEs leading to new hospitalization and prolonged hospitalizations. Overall, there was no correlation between a positive IOBC and a patient developing an AE.ConclusionsThe findings of this study provide insights that improve the infectious management of patients undergoing IRE.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference50 articles.

1. Institute NC. SEER Cancer Statistics Review 1975‐2013.https://seer.cancer.gov/archive/csr/1975_2013/results_merged/sect_22_pancreas.pdf. Accessed 5/22/2018 2018.

2. Institute NC. SEER Stat Fact Sheets: Pancreas Cancer.http://seer.cancer.gov/statfacts/html/pancreas.html. Accessed 5/18/2022 2018.

3. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

4. Therapeutic options for the management of pancreatic cancer

5. Pancreatic cancer: advances in treatment;Mohammed S;World J Gastroenterol,2014

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3